Lilly bracing for demand crush for newly approved obesity drug

The Indianapolis-based company said Wednesday that its newest product, a drug for obesity called Zepbound, will be on pharmacy shelves shortly after Thanksgiving. The company is ramping up manufacturing capacity to avoid possible shortages and to meet potentially huge demand in a nation where more than 40% of adults are classified as obese.... Read More

Rural health care gaps complicate health outcomes. Where does Indiana stand?

Rural Hoosiers face a number of barriers furthering the accesibility of adequate health care, forcing them to likely drive farther, maneuver around a large-scale provider shortage and use internet services unavailable to them as well as deal with universal issues such as cost and insurance coverage issues. Lack of access can often equate to a lack of care when roadblocks to preventative and primary care are too severe.... Read More